| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |